ACE inhibitors and Angiotensin Receptor Blockers may still be used for the treatment of hypertension in patients with or without COVID-19.

 

2

  • This statement was separately shared by the Philippine Heart Association1 and Philippine Society of Hypertension2 since March/ April 2020 after reviewing data from research articles worldwide and seeking the opinion of local experts.

  • The most recent research articles published this year still support this statement and a similar recommendation was mentioned in the Philippine COVID 19 Living Recommendations3 released on April 27, 2021

 

1.https://www.philheart.org/index.php/learn-more/guidelines-and-statements/179-statements/896-hypertension-and-covid-19-statement-and-summary-of-information-from-the-council-on-hypertension-28-april-2020

2. https://www.philippinesocietyofhypertension.org.ph/COVID-19_and_High_Blood_Pressure.pdf

3. https://www.psmid.org/raas-blockers-evidence-summary/

3

  • Pareho ang pahayag ng Philippine Heart Association at Philippine Society of Hypertension noon pang March/April 2020 base sa pagsusuri ng mga datos na nakalap mula sa research trials sa buong mundo at base na din sa mga local experts.

  • Ang mga pinakabagong datos ngayong taon ay alinsunod pa din sa pahayag na ito. Ang pahayag na ito ay nilalaman din ng pinakabagong Philippine COVID 19 Living Recommendations na inilathala nuong April 27, 2021.

* Calcium channel blockers: mga gamot na may -dipine sa dulo, Beta blockers : mga gamot na may-olol sa dulo, Diuretics: mga gamot na may -ide  sa dulo

1. ACE Inhibitors: mga gamot na may -pril sa dulo kagaya ng Captopril, Enalapril, Imidapril, Perindopril,

2. Angiotensin Rceptor Blockers: mga gamot na may -sartan sa dulo kagaya ng Irbesartan, Losartan, Olmesartan Telmisartan, Valsartan


Copyright © 2021. Philippine Heart Association.
All Rights Reserved. PHA Privacy Statement
No Internet Connection